IFF Pharma Solutions will shine a light on its technology
advancements through its flagship products that demonstrate how
timing is everything
NEW
YORK, May 15, 2024 /PRNewswire/ -- IFF (NYSE:
IFF), a global leader in food and beverage, home and personal care
and health, today announced a new controlled release platform for
its portfolio of controlled release products including METHOCEL™,
ETHOCEL™, and POLYOX™. Under the banner, "Timing is
Everything," the platform provides comprehensive solutions for
pharmaceutical therapies to benefit patients and highlights the
importance of controlled release of active ingredients and
improving patient compliance. Complete with educational materials
for partners, resources, and access to subject matter experts, the
platform can be found at
https://pharma.iff.com/controlled-release-platform, where you can
also register for an upcoming complimentary educational
webinar.
"We are excited to launch the 'Timing is Everything' platform,
celebrating our portfolio of controlled release products, to
further support pharmaceutical formulators and continue providing
more effective options for patients," said Jason Hunt, global strategic marketing manager,
IFF Pharma Solutions. "Our experience, knowledge and aptitude for
problem-solving help ensure our partners' therapeutic innovations
get to market faster."
About Controlled Release
Controlled release formulations are particularly beneficial when
specificity is needed, including reduced dosing frequency, enhanced
safety profiles, and minimized side effects. These benefits
contribute to better patient compliance and treatment adherence. As
a result, controlled release dosage forms continue to gain
prominence as one of the most dynamic delivery systems in the
pharmaceutical landscape.
For over 70 years, IFF Pharma Solutions has been a trailblazer
in the controlled release domain, continually introducing
groundbreaking products that redefine the standards of drug
delivery. The company's signature offerings — METHOCEL™, ETHOCEL™,
and POLYOX™ — have not only laid the groundwork for the sector but
also persist in propelling forward-thinking solutions to meet
intricate drug delivery demands.
METHOCEL™ — Pioneering Then, Innovating Now
In a steadfast commitment to innovation, METHOCEL™ cellulose
ethers remain the top choice for controlled-release matrix
formulations. Offering a versatile range of methylcellulose (MC)
and hydroxypropyl methylcellulose (HPMC) products, METHOCEL™ caters
to a broad spectrum of formulation characteristics. With a
long-standing history of reliability in pharmaceutical
applications, it continues to deliver unparalleled efficacy in both
solid and liquid dosage forms.
ETHOCEL™ — Proven Time After Time
ETHOCEL™ ethylcellulose polymer products are distinguished by
their organosolubility, precise specification ranges, and uniform
ethoxyl functionality. Renowned as the polymer of choice for
coating multi-particulates, ETHOCEL™ is indispensable for attaining
modified release and superior taste-masking in various
pharmaceutical applications.
POLYOX™ — Versatile Across Complex and Unique
Applications
POLYOX™ polyethylene oxide products are recognized for their
pivotal role in osmotic pump delivery systems and are equally adept
in specialty matrices that demand distinctive characteristics such
as high swelling, mucoadhesion, abuse deterrence, and exceptional
mechanical strength.
"We are proud to help customers find answers at every turn,"
said Paula Garcia Todd, global
applications, development and innovation director, IFF Pharma
Solutions. "Our passion for perfecting technologies for controlled
release—to help improve the quality of patients' lives— drives us
to innovate. As we celebrate our history of leadership, and plan
future innovative solutions, we remain focused on what we call our
'everyday innovations.' From METHOCEL™ to ETHOCEL™ and POLYOX™, our
products offer customized solutions for various release
profiles."
IFF Pharma Solutions will host a webinar titled, "Controlled
Release Redefined: The Strategic Use of Excipients in Formulation"
on June 12, 2024. The webinar will
cover the nuances of controlled release formulations, the influence
of excipient physiochemical properties on release performance, and
how strategic choices in these properties can help formulators
develop distinct controlled release delivery systems. To register,
please sign up at the link.
Welcome to IFF
At IFF (NYSE: IFF), an industry leader in food, beverage,
health, biosciences and scent, science and creativity meet to
create essential solutions for a better world – from global icons
to unexpected innovations and experiences. With the beauty of art
and the precision of science, we are an international collective of
thinkers who partner with customers to bring scents, tastes,
experiences, ingredients and solutions for products the world
craves. Together, we will do more good for people and planet.
Learn more at
iff.com, Twitter , Facebook, Instagram,
and LinkedIn.
©2024 International Flavors & Fragrances Inc. (IFF). IFF,
the IFF Logo, and all trademarks and service marks denoted with ™,
℠ or ® are owned by IFF or affiliates of IFF unless otherwise
noted. All Rights Reserved.
Contact:
Lisa Luke
Global Communications Director
+1 302-927-9234
lisa.luke@iff.com
SOURCE IFF